Due to its wide-spectrum of regulatory effects, mutations in PPARγ have been identified in the humans and led to dysfunctional lipid and glucose metabolism, insulin resistance, which developed into obesity-induced T2DM, dyslipidemia, NAFLD, and cancer [15–18]. The gene discussed is PPARG; the disease is obesity due to melanocortin 4 receptor deficiency.